In This Section

Continuing Medical Education

Accreditation Statement

The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

Credit Designation Statement

AACR has designated this live activity for a maximum of 17.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Credit certification for individual sessions may vary, dependent upon compliance with the ACCME Accreditation Criteria. The final number of credits may vary from the maximum number indicated above.

Claiming (CME) Credit

Physicians and other health care professionals seeking AMA PRA Category 1 Credit(s)TM for this live continuing medical education activity must complete the online CME Request for Credit Survey by Friday, November 15, 2020. Certificates will only be issued to those who complete the survey. The Request for Credit Survey will be available via a link on this website and via email. Your CME certificate will be sent to you via email after the completion of the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.  

To receive ABIM MOC, participants must request MOC in the CME Request for Credit Survey and complete all questions. Once these steps are completed, AACR will submit your completion information via the ACCME’s Program and Activity Reporting System for the purpose of granting MOC points.

Statement of Educational Need, Target Audience, and Learning Objectives

According to the U.S. National Cancer Institute, pancreatic cancer will account for approximately 45,750 deaths in 2019. Pancreatic cancer will account for just 3.2% of all new cancer cases but will account for 7.5% of all cancer deaths.  Despite advances in recent years, the 5-year survival rate is only at 9.3% – making pancreatic cancer one of the most lethal malignant neoplasms.1

Because patients seldom exhibit symptoms until an advanced stage of the disease, early detection and diagnosis are a primary area of concern in pancreatic cancer research. 2 With sessions dedicated to highlighting recent clinical advances made in the field, genetic testing and precision oncology, imaging, early detection and screening, immunologic therapies, homeostatic mechanisms and responses, metabolic and tumor microenvironment influences, research advances achieved in these areas have the potential to translate into wider treatment options and improved patient outcomes for this disease.

Practicing oncologists and clinical investigators focused on pancreatic cancer will be drawn to the program to hear about emerging new research and approaches in the areas of genomics and precision oncology, advanced imaging, early detection and screening and immunotherapy.

After participating in this CME activity, physicians should be able to:

  1. Assess therapeutic strategies that combine genomic research with precision medicine.
  2. Identify immunological and metabolic contributions towards pancreatic cancer initiation, progression and treatment response
  3. Evaluate recent clinical advances made in treating pancreatic cancer
  4. Articulate the role of tumor microenvironment in influencing pancreatic cancer disease states.
  5. Implement novel approaches that allow for screening and early detection of pancreatic tumors.

Disclosure Statement

It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, AACR will provide information that Scientific Program Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information will be made available in the Program/Proceedings of this conference.

Acknowledgment of Financial or Other Support

This activity is supported by Professional Educational Grants which will be disclosed at the activity.

Questions about CME?

Please contact the Office of CME at (215) 440-9300 or